Clinical Trial Update: A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) [Phase 4]

View source ↗

Summary

An ongoing Phase 4 clinical trial evaluating whether the 9-valent HPV vaccine (Gardasil-9) reduces HPV infectivity and transmission among HPV-positive women, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Miquel Angel Pavon Ribas | Conditions: Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections | Phase 4 | Status: RECRUITING